What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Cell biology, Embryonic stem cell, Cellular differentiation, Internal medicine and Stem cell are his primary areas of study.
Ronald A. Li interconnects Inotrope and Dihydropyridine in the investigation of issues within Cell biology.
His research integrates issues of Cell culture, Receptor and Nanotechnology in his study of Embryonic stem cell.
His studies deal with areas such as Progenitor cell, microRNA and Anatomy as well as Cellular differentiation.
His Internal medicine research incorporates themes from Endocrinology and Cardiology.
His Stem cell study combines topics from a wide range of disciplines, such as Transplantation, Immunology, Regeneration and Pathology.
His most cited work include:
- Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes Insights Into the Development of Cell-Based Pacemakers (452 citations)
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. (368 citations)
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. (368 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cell biology, Embryonic stem cell, Induced pluripotent stem cell, Internal medicine and Stem cell.
His Cell biology research includes elements of Cell culture, Calcium and Anatomy.
His studies in Embryonic stem cell integrate themes in fields like Molecular biology, Cell, Cellular differentiation and Transplantation.
Within one scientific family, Ronald A. Li focuses on topics pertaining to microRNA under Cellular differentiation, and may sometimes address concerns connected to Pathogenesis.
The Induced pluripotent stem cell study combines topics in areas such as Drug, Cardiotoxicity, Neuroscience and Drug discovery.
The various areas that Ronald A. Li examines in his Internal medicine study include Endocrinology, In vivo and Cardiology.
He most often published in these fields:
- Cell biology (79.66%)
- Embryonic stem cell (64.41%)
- Induced pluripotent stem cell (54.58%)
What were the highlights of his more recent work (between 2016-2021)?
- Induced pluripotent stem cell (54.58%)
- Cell biology (79.66%)
- Internal medicine (33.56%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Induced pluripotent stem cell, Cell biology, Internal medicine, Embryonic stem cell and Cardiotoxicity.
His Induced pluripotent stem cell study incorporates themes from Phenotype, Transcriptome, microRNA, Drug and Drug discovery.
Particularly relevant to Stem cell is his body of work in Cell biology.
His Internal medicine study integrates concerns from other disciplines, such as Gene transfer, Endocrinology and Cardiology.
As a part of the same scientific family, Ronald A. Li mostly works in the field of Embryonic stem cell, focusing on Endoplasmic reticulum and, on occasion, Signal transduction.
His Cardiotoxicity study also includes fields such as
- Cancer chemotherapy which connect with Oncology,
- Organ-on-a-chip which connect with Biomedical engineering.
Between 2016 and 2021, his most popular works were:
- Wearable sensors: modalities, challenges, and prospects (280 citations)
- Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. (65 citations)
- Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells (47 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of study are Induced pluripotent stem cell, Cell biology, Stem cell, Myocyte and Drug.
His Induced pluripotent stem cell research is multidisciplinary, relying on both Ventricle, Contractility, Human heart and Drug discovery.
Ronald A. Li mostly deals with Regenerative medicine in his studies of Cell biology.
His Stem cell research includes themes of Autophagy, Electrophysiology, Pacemaker potential, Anatomy and Cell sorting.
His Myocyte research is multidisciplinary, incorporating perspectives in Sudden death, Bioinformatics, Toxicology, Cardiotoxicity and Mass screening.
The concepts of his Sarcomere study are interwoven with issues in Embryonic stem cell, Cell and Cardiac muscle.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
